Last reviewed · How we verify

NCT05436197

The Expansion of a Parent-focused Physical Literacy Intervention for Early Childhood Called PLAYshop

Completed NA Last updated 11 December 2024
What this trial tests

NA trial testing PLAYshop Program in Motor Activity in 32 participants. Completed in 6 February 2024.

Timeline
18 July 2022
Primary endpoint
6 February 2024
6 February 2024

Quick facts

Lead sponsorUniversity of Alberta
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment32
Start date18 July 2022
Primary completion6 February 2024
Estimated completion6 February 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Alberta

Who can join

Adults 3 to 5, any sex, with Motor Activity or Parent-Child Relations. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The PLAYshop program is a novel, brief, theory-based, parent-focused physical literacy intervention, that can help mitigate the impacts of the COVID-19 pandemic on physical activity of children from diverse and vulnerable families who have been disproportionally affected by the COVID-19 Pandemic. Primary Research Question: Among vulnerable families (e.g., lower socioeconomic status), does the PLAYshop program increase parental capability, opportunity, and motivation to support preschool-aged children's physical literacy development, compared to controls?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Motor Activity

Currently open trials in the same condition.

Other University of Alberta trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05436197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing